|
Market Closed -
Xetra
16:35:30 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 4.680 EUR | -0.43% |
|
-2.50% | -19.31% |
| 09-17 | Novo, Orbis sign up to $1.4 billion deal to develop oral drugs | RE |
| 08-19 | ORBIS AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ORBIS AG | Other IT Services & Consulting | -0.43% | -2.50% | -19.31% | -19.31% | -39.61% | 49.69M |  |  | |
- Stock Market
- Stocks
- OBS Stock
- Charts ORBIS AG
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
